Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Risk Assessment after Acute Myocardial Infarction in Patients with Type 2 Diabetes
posted on 2020-04-21, 15:31authored byAda AdminAda Admin, Sören J. Backhaus, Johannes T. Kowallick, Thomas Stiermaier, Torben Lange, Jenny-Lou Navarra, Alexander Koschalka, Ruben Evertz, Joachim Lotz, Shelby Kutty, Gerd Hasenfuß, Matthias Gutberlet, Holger Thiele, Ingo Eitel, Andreas Schuster
Type 2 diabetes mellitus predicts outcome following acute myocardial infarction (AMI). Since underlying
mechanics are incompletely understood, we investigated left ventricular (LV) and
atrial (LA) pathophysiological changes and their prognostic implications using
cardiovascular magnetic resonance (CMR). Consecutive patients (n=1147, n=265 diabetic; n=882 non-diabetic)
underwent CMR 3 days after AMI. Analyses included LV ejection fraction (LVEF),
global longitudinal, circumferential and radial strains (GLS, GCS and GRS), LA
reservoir, conduit and booster pump strains, as well as infarct size, edema and
microvascular obstruction. Predefined endpoints were major adverse cardiovascular
events (MACE) within 12 months. Diabeticpatients had impaired LA reservoir
(19.8 vs. 21.2%, p<0.01) and conduit strains (7.6 vs. 9.0%, p<0.01) but
not ventricular function or myocardial damage. They were at higher risk of MACE
than non-diabetic patients (10.2% vs. 5.8%, p<0.01) with most MACE occurring
in patients with LVEF≥35%. Whilst LVEF (p=0.045) and atrial reservoir strain
(p=0.024) were independent predictors of MACE in non-diabetic patients, GLS was
in diabetic patients (p=0.010). Considering patients with diabetes and LVEF≥35%
(n=237), GLS and LA reservoir strain below median were significantly associated
with MACE. In conclusion, in patients with diabetes, LA and LV longitudinal strain permit optimized
risk assessment early after reperfused AMI with incremental prognostic value
over and above LVEF.
Funding
This study was funded by the DZHK (German Centre for Cardiovascular Research).